/biz/ - Business & Finance

AI will have a much larger impact on medicine than what's been posted so far. It's going to lower the bar to drug design massively, which will increase competition in the pharma industry & take many new drugs to market as a result.

That combined with cas9 poise bioengineering to see massive leaps in capability in the next few decades

With optimization research like RWKV, sequence to sequence AI models are becoming more and more practical to apply to genomics databases

AI grows the set of problems with tractable kolmogorov complexity. Creating systems that learn drug interactions is newly practical as a result e.g.

https://www.deepmind.com/research/highlighted-research/alphafold
https://en.wikipedia.org/wiki/Cas9
https://arxiv.org/pdf/2307.04603.pdf
https://arxiv.org/pdf/2306.03606.pdf
https://en.wikipedia.org/wiki/Kolmogorov_complexity